维普期刊资源整合服务平台（V6.5）

63篇 您的检索式：作者名="Cusack JC"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB 显示文摘	Wang CY Cusack JC Jr Liu R	1999	Nat Med1999，5，4：	1
2	Inducible chemoresistance to 7-ethyl- 10--carbonyloxycamp to the c in (CPT- 11 ) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kapp-a B activation显示文摘	Cusack JC Jr Liu R Baldwin AS Jr	2000	Cancer Res2000，60，4：	1
3	ECPT-I1 with proteasome inhibitor PS-341 :implications for systemic nuclear factor-KB inhibition 显示文摘	Cusack JC Rong L Houston M	2001	Cancer Res2001，61，：	1
4	Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas显示文摘	Weaver KD Yeyeodu S Cusack JC Jr		0，，：	1
5	Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341显示文摘	Cusack JC Liu R Houston M	2001	Cancer Res2001，61，5：	1
6	Control of inducible chemoresistance: enhanced anti-tumor therpy through increased apoptosis by inhibition of NF-κB显示文摘	Wang CY Cusack JC Liu R	1999	Nat Med1999，5，：	1
7	Control of inducible chemoresistance:enhanced anti-tumor therapy through increased apoptosisby inhibition of NF-kappaB显示文摘	Wang CY Cusack JC Jr Liu R		0，，04：	1
8	Enhanced chemosensitivity to CPT - 11 with proteasome inhibitor PS - 341 : implications tor systemic nuclear tactor-kB inhibition显示文摘	Cusack JC Jr Liu R Houston M	2001	Cancer Res2001，61，9：	1
9	Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB显示文摘	Wang CY Cusack JC Liu R	1999	Nature Med1999，5，4：	1
10	Managing unsuspected tumor invasion of the superior mesenterie-portal venous confluence during pancreaticoduodenectomy 显示文摘	Cusack JC Jr Fuhrman GM Lee JE	1994	Am J Surg1994，168，：	1
11	Wild-type human p 53 and atemperature-sensitive mutant induce Fas/APO-1 expression显示文摘	Owen-Schaub LB Zhang W Cusack JC	1995	Mol Cell Biol,1995，15，6：	1
12	Fas and Fas ligand interactions in malignant disease显示文摘	Owen-Schaub L Chan H Cusack JC	2000	Int J Oncol2000，17，1：	1
13	Overcoming Antiapoptotic Responses to Promote Chemosensitivity in Metastatic Colorectal Cancer to the Liver显示文摘	Cusack JC Jr	2003	Ann Surg Oncol2003，10，8：	1
14	Enhanced chemosensitivity to CPT-11 with proteasome inhibitor P8-341: implications for systemic nuclear facto-kB inhibition显示文摘	Cusack JC Rong L Houston M	2001	Cancer Res2001，61，：	1
15	Survival factors in186 patients younger than g0 years old with colorectal adenocarcinoma显示文摘	Cusack JC Giacco GC Cleary K	1996	Am Coll Surg1996，183，2：	1
16	Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341 : implications for systemic nuclear factor-κB inhibiton显示文摘	CUSACK JC Jr LIU R HOUSTON M	2001	Cancer Res2001，61，9：	1
17	Wild type human p53 and a temperature sensitive mutant induced Fas/Apo-1 expression 显示文摘	Owen-shaub LB Zhang W Cusack JC	2003	Mol Cell Biol2003，，15：	1
18	NF-κB and chemoresistance: potentiation of cancer drugs via inhibiton of NF-κB显示文摘	CUSACK JC LIU R BALDWIN AS	1999	Drug Resist Updat1999，2，4：	1
19	Survival factors in 186 pa- tients younger than 40 years old With colorectal adenocarcinoma显示文摘	Cusack JC Giacco GG Cleary K	1996	J Am Coil Surg1996，183，2：	1
20	Fas and Fas ligand interactions in malignant disease显示文摘	Chan H Cusack JC	2000	Int J Oncol2000，17，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示